PRIMARY STUDY

Potential use for chronic pain: Poly(Ethylene Glycol)-Poly(Lactic-Co-Glycolic Acid) nanoparticles enhance the effects of Cannabis-Based terpenes on calcium influx in TRPV1-Expressing cells

Key Findings:  Resulting data led the authors to conclude that terpene-encapsulated poly(ethylene glycol)-poly(lactic-co-glycolic acid) nanoparticles (i.e., β-myrcene, β-caryophyllene, and nerolidol) may be novel therapeutics compounds in the treatment of chronic pain.

Type of Study:  Laboratory Study

Study Result:  Positive

Study Location(s):  Spain, United States

Year of Pub:  2022


Cannabinoids Studied: 

Phytocannabinoid Source:  Not Applicable

Terpenes Studied:  ß-Caryophyllene, Myrcene, Nerolidol

Receptors Studied:  TRPV1

Route of Administration:  In vitro



Link to study